Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by JLGeminion Feb 22, 2011 2:07pm
302 Views
Post# 18174751

NASDAQ Reports Smart Money Is Buying

NASDAQ Reports Smart Money Is Buying

The Dec 31 positions are being reported on the NASDAQ website for ONCY.  Intuitional investors are buying into ONCY, big time.  The reported net activity was an increase of 8,141,527 shares for a total holding of 9,559,408 shares dispersed over 34 institutional investors.

 

Acuity Investment surpassed Harris Financial, 1,297,690 shares, as the largest reported shareholder by acquiring 6,344,260 more shares to hold 6,532,060.  New institutional investors were Franklin Resources, 781,600, Intact Investment, 250,500, and AGF, 144,000.  Increasing their holdings were Vertex One Asset Management by 65,000 to 130,000, Morgan Stanley by 65,950 to 83,800, and Counsel Portfolio Services by 45,600 to 52,000.

 

The big sellers were CPP and RBC.  These positions may have migrated north to ONC for currency or other reasons.  CPP sold 504,000 shares to hold a modest 6,900 while RBC sold 132,959 to hold 2,462.

 

With institutional investors buying in this volume, what retail investor in their right mind would consider selling?

 

Bullboard Posts